CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 89 enrolled
Drug / intervention
INVSENSOR00069device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06120777
NCT06120777N/ACompleted
CompareCT.gov

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Masimo Corporation·interventional·Posted Nov 7, 2023·Updated Nov 27, 2024

In Brief

A clinical study evaluating INVSENSOR00069 for Healthy. Completed, enrolled 89 participants across 1 site.

Detailed Summary

Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 7, 2023
Enrollment StartNov 1, 2023
Primary CompletionDec 12, 2023
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 2.7 years ago

Interventions

INVSENSOR00069device

Noninvasive pulse oximeter